Clinical Trial Update: A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF) [Phase 2]

View source ↗

Summary

This update notes a Phase 2 clinical trial evaluating IV HBI-3000 for conversion of recent-onset atrial fibrillation, which is currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• HBI-3000 (HBI-3000)

Snippet

Sponsor: HUYABIO International, LLC. | Conditions: Atrial Fibrillation | Phase 2 | Status: ACTIVE_NOT_RECRUITING